# The Effect of Albumin Supplementation on the Inflammatory and Oxidative Stress Markers in Septic Patients

> **NCT03950778** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Pecs** · enrollment: 30 (estimated)

## Conditions studied

- Albumin Supplementation
- Albumin Therapy
- Sepsis

## Interventions

- **DRUG:** Human albumin

## Key facts

- **NCT ID:** NCT03950778
- **Lead sponsor:** University of Pecs
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950778, "The Effect of Albumin Supplementation on the Inflammatory and Oxidative Stress Markers in Septic Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03950778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*